|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Opioid Receptor Function by Up-Regulation of Membrane Receptors in Mouse Primary Afferent Neurons
Department of Psychiatry and Biobehavioral Sciences, Center for Health Sciences, University of California, Los Angeles, California (W.W., N.T.M., C.J.E.); Psychology Department, University of California, Los Angeles, Los Angeles, California (M.S.); Institute of Genetics and Molecular and Cellular Biology, Centre National de la Recherche Scientifique/Institut National de la Sante et de la Recherche Medicale/Université Louis Pasteur, Illkirch, France (B.L.K.); and Departments of Pharmacology & Physiology and Anesthesiology & Critical Care Medicine, the George Washington University, Washington, DC (T.G.H.)
It is not clear whether primary afferent neurons express functional cell-surface
opioid receptors. We examined
receptor coupling to Ca2+ channels in mouse dorsal root ganglion neurons under basal conditions and after
receptor up-regulation. [D-Ala2,Phe4,Gly5-ol]-enkephalin (DAMGO), [D-Ala2,D-Leu5]-enkephalin (DADLE), trans-(±)-3,4-dichloro-N-methyl-N-(2-[1-pyrrolidinyl]cyclohexyl) benzene-acetamide methanesulfonate (U-50,488H; 1 µM), and baclofen (50 µM) inhibited Ca2+ currents, whereas the
-selective ligands [D-Pen2,Pen5]-enkephalin (DPDPE) and deltorphin II (1 µM) did not. The effect of DADLE (1 µM) was blocked by the µ-antagonist D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP; 300 nM) but not by the
-antagonist Tyr-1,2,3,4-tetrahydroisoquinoline-Phe-Phe-OH (300 nM), implicating µ receptors. Despite a lack of functional
receptors, flow cytometry revealed cell-surface
receptors. We used this approach to identify conditions that up-regulate
receptors, including µ receptor gene deletion in dorsal root ganglion neurons of µ-/- mice and 18-h incubation of µ+/+ neurons with CTAP followed by brief (10-min) DPDPE exposure. Under these conditions, the expression of cell-surface
receptors was up-regulated to 149 ± 9 and 139 ± 5%, respectively; furthermore, DPDPE and deltorphin II (1 µM) inhibited Ca2+ currents in both cases. Viral replacement of µ receptors in µ-/- neurons reduced
receptor expression to µ+/+ levels, restored the inhibition of Ca2+ currents by DAMGO, and abolished
receptor coupling. Our observations suggest that
receptor-Ca2+ channel coupling in primary afferent fibers may have little functional significance under basal conditions in which µ receptors predominate. However, up-regulation of cell-surface
receptors induces their coupling to Ca2+ channels. Pharmacological approaches that increase functional
receptor expression may reveal a novel target for analgesic therapy.
Address correspondence to: Dr. Tim G. Hales, Department of Pharmacology and Physiology, Medical Center, The George Washington University, 2300 Eye Street NW, Washington, DC 20037. E-mail: phmtgh{at}gwumc.edu.
This article has been cited by other articles:
![]() |
F. M. Decaillot, R. Rozenfeld, A. Gupta, and L. A. Devi Cell surface targeting of {micro}-{delta} opioid receptor heterodimers by RTP4 PNAS, October 14, 2008; 105(41): 16045 - 16050. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Walwyn, C. J. Evans, and T. G. Hales {beta}-Arrestin2 and c-Src Regulate the Constitutive Activity and Recycling of {micro} Opioid Receptors in Dorsal Root Ganglion Neurons J. Neurosci., May 9, 2007; 27(19): 5092 - 5104. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Scherrer, P. Tryoen-Toth, D. Filliol, A. Matifas, D. Laustriat, Y. Q. Cao, A. I. Basbaum, A. Dierich, J.-L. Vonesh, C. Gaveriaux-Ruff, et al. Knockin mice expressing fluorescent {delta}-opioid receptors uncover G protein-coupled receptor dynamics in vivo PNAS, June 20, 2006; 103(25): 9691 - 9696. [Abstract] [Full Text] [PDF] |
||||